Overcoming drug resistance of cancer cells by targeting the FGF1/FGFR1 axis with honokiol or FGF ligand trap
Our results shed light on how blocking the FGF1/FGFR1 axis by honokiol and FGF ligand trap could help develop more effective cancer therapies, potentially preventing the emergence of drug-resistant relapses.
Authors
- Martyna Biaduń (ORCID: https://orcid.org/0000-0002-2648-6593)
- Jakub Szymczyk (ORCID: https://orcid.org/0000-0003-2022-8064)
- Katarzyna Dominika Służalska (ORCID: https://orcid.org/0000-0002-6307-0204)
- Małgorzata Zakrzewska (ORCID: https://orcid.org/0000-0001-8214-1533)
- Martyna Sochacka
- Dorota Witkowska (ORCID: https://orcid.org/0000-0001-9538-9589)
Institutions
- University of Opole (PL)
- University of Wrocław (PL)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-09-12
- DOI
- https://doi.org/10.3389/fphar.2024.1459820
- Citations
- 1
- Primary Topic
- Magnolia and Illicium research
- Type
- article
- Field-Weighted Citation Impact
- 0.25